Carlos Lopera

Early tocilizumab treatment could improve survival among COVID-19 patients.

R. Boixeda, L. Force, L. Campins, 2020, Clinical and experimental rheumatology.

Real-life use of remdesivir in hospitalized patients with COVID-19

Felipe García, Á. Soriano, P. Castro, 2021, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Infection with the Omicron variant of SARS-CoV-2 is associated with less severe disease in hospitalized patients with COVID-19

Á. Soriano, José A. Martínez, J. Mensa, 2022, Journal of Infection.

Bacterial co-infection at hospital admission in patients with COVID-19

Á. Soriano, P. Castro, José A. Martínez, 2022, International Journal of Infectious Diseases.

Prolonged viral replication in patients with hematologic malignancies hospitalized with COVID-19

E. Giné, A. Gaya, M. Bodro, 2022, Haematologica.

Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals.

J. Esteve, Á. Soriano, J. Mensa, 2023, The Journal of antimicrobial chemotherapy.

High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations

Á. Soriano, C. García-Vidal, C. Gudiol, 2023, Microbiology spectrum.

Identifying the most important data for research in the field of infectious diseases: thinking on the basis of artificial intelligence

C. Cardozo, C. García-Vidal, P. Puerta-Alcalde, 2023, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Emergence of carbapenem-resistant Pseudomonas aeruginosa ST179 producing both IMP-16 and KPC-2: a case study of introduction from Peru to Spain

I. Roca, J. Viñes, C. Pitart, 2024, Microbiology spectrum.

Prevalence and impact of multidrug-resistant bacteria in solid cancer patients with bloodstream infection: a 25-year trend analysis.

C. Pitart, L. Morata, P. Puerta-Alcalde, 2024, Microbiology spectrum.

Safety and effectiveness of isavuconazole in real-life non-neutropenic patients.

P. Martín-Dávila, I. Ruiz-Camps, C. Gudiol, 2024, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.